| Serial Number | 99208934 |
| Word Mark | EXCELLERGY |
| Filing Date | Thursday, May 29, 2025 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, July 17, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 25, 2025 |
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; chemical and biological diagnostic preparations and substances for medical or veterinary purposes used by clinical and medical laboratories in drug discovery and nucleic acid and protein therapeutics |
| Goods and Services | Providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding the diagnostic, prophylactic and therapeutic properties of pharmaceuticals and the treatment and prevention of various illnesses, disorders and maladies; providing health and medical information about pharmaceuticals; information services, namely, providing medical information to patients; providing medical consultancy and advisory services via a global computer network in the fields of pharmaceuticals and various illnesses, disorders and maladies |
| Goods and Services | Biotechnology, medical and scientific research and development services in the field of protein therapeutics and diagnostics; biotechnology research services, namely, protein therapeutics development for applications in the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; biotechnology research services, namely, protein therapeutics development for applications in the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical, pharmaceutical and scientific research and development services in the field of protein therapeutics and diagnostics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 29, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Excellergy, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94306 US |
| Party Name | Excellergy, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Palo Alto, CA 94306 US |
| Event Date | Event Description |
| Thursday, May 29, 2025 | NEW APPLICATION ENTERED |
| Thursday, May 29, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 8, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 17, 2025 | ASSIGNED TO EXAMINER |
| Monday, October 20, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, October 20, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, October 20, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 23, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 23, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 19, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 25, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 25, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 20, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 14, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 14, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 14, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 14, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 14, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, July 17, 2026 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 17, 2026 | SOU EXTENSION 1 FILED |
| Friday, July 17, 2026 | SOU EXTENSION 1 GRANTED |
| Saturday, July 18, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |